Real Endpoints, a health-care advisory/analytics firm delivering solutions that enhance appropriate access to innovation. https://xitter.cf/t.co/50bRL3Vi56

25A Hanover Rd Florham Park NJ
Joined July 2015
RealEndpoints retweeted
From @RealEndpoints: A Solution to the #Medicare Copay Problem Read the article: drugch.nl/34B2lws Register for the free webcast: drugch.nl/34icJce #ad
3
6
RealEndpoints retweeted
I recently talked @spark_tx with @RealEndpoints CEO Roger Longman on the @OISTWEETS ois.net/what-spark-did-right…. Great insights on Spark's successful pricing strategy. #ophthalmology
3
2
RT @ISPORorg: #Value Assessments should be interactive, adaptable, and transparent. - Longman of @RealEndpoints #ISPORvaf #healtheconomics
RealEndpoints retweeted
Health plans reach deal w/NY State to remove restrictions on hepatitis C meds.. statnews.com/pharmalot/2016/… #pharma $GILD $ABBV $MRK
5
2
U.S. docs know scarily little about the FDA process for new drugs, according to a JAMA survey: ow.ly/10Cyup via @PharmaceuticBen
4
2
RealEndpoints retweeted
'Breakthrough' can be an effective marketing term for some drugs.. why? read what docs think.. statnews.com/pharmalot/2016/… #pharma #FDA
2
3
Prescription drug growth rate continues to outstrip other areas of healthcare: 8.4pct net of discounts in '14 washingtonpost.com/business/…
4
4
RealEndpoints retweeted
A beautifully written, important piece by @HealthEconTX about regulation, compassion, and her father's care. thehill.com/blogs/pundits-bl…
4
6
Samsung brings in the lawyers for biosimilars push reut.rs/223xwCE
5
2
And you thought drug-pricing controversies were dying down… $MDVN xitter.cf/megtirrell/status/7145…
12 congressmen ask NIH, HHS to examine $MDVN's Xtandi pricing. Letter here: sanders.senate.gov/download/…
1
9
5
.@SteveUbl of @PhRMA and @npc weigh in on Rx value frameworks at a time when value is in eye of beholder. thehill.com/blogs/congress-b… – at Sunnyvale, CA
ICYMI: Regeneron/Sanofi team hustling to the FDA with stellar PhIII dupilumab data: ow.ly/10ar7p via @JohnCFierce $SNY $REGN
RealEndpoints retweeted
Here comes price increases for anti-PD1 $MRK just took price increase on Keytruda by 1.5%. Expect $BMY to do the same in “shadow pricing”
14
19
ICYMI: FDA publishes more biosimilar labeling advice after pharma voices its concerns: ow.ly/10aFQY by @PharmaceuticBen
1
2
Under pressure to digitize everything, hospitals are hackers' biggest new target wpo.st/LJOR1
1
9
8
RealEndpoints retweeted
At current pace, health care will become the biggest job sector in America within 3 years.
20
154
86
RealEndpoints retweeted
Physician Group Calls On Government To Rein In Drug Prices n.pr/1REklWe
39
36
RealEndpoints retweeted
Drug makers inconsistently report side effects to US and European regulators: study.. read it here.. statnews.com/pharmalot/2016/… #pharma #FDA
9
7
RealEndpoints retweeted
Buying Costly Drugs On The Installment Plan: Could It Work? n.pr/1RC6cZz
5
14
6